STARRY SEA ACQUISITION CORP

According to Exhibit 99.1, Starry Sea Acquisition Corp completed an underwritten initial public offering of 5,750,000 units via A.G.P./Alliance Global Partners, with the Securities and Exchange Commission declaring the governing registration statement (File Number 333-287976) effective on August 7, 2025. The press release identifies Yan Liang as Chief Executive Officer and lists Kong Wai Yap as Chief Financial Officer. Each unit comprises one ordinary share carrying a par value of $0.0001 plus the aforementioned conditional right. By splitting the combined security into two independently tradable instruments, the Company alters the secondary market liquidity profile without modifying the underlying capitalization table or business combination timeline. Investors monitoring pre-combination positioning should track how volume and bid-ask spreads distribute across SSEA and SSEAR, as differential pricing between the equity and the fractional conversion right may signal early institutional allocation shifts ahead of any formal target announcement or proxy solicitation.

The filing advances SSEA from its searching phase into binding deal execution, locking in a valuation band and a sixty (60) day exclusivity window while formally requiring target access to trust account and redemption scenario data prior to any definitive agreement. Investors tracking redemption economics and trust preservation will note that the referenced $10 per share valuation is an equity consideration metric rather than a stated cash redemption price, meaning actual trust distribution mechanics, third-party PIPE sizing, and pro forma share counts remain undefined until the proxy statement. The absence of an extension declaration or updated trust ledger means current shareholder exit rights and timing continue to operate under the original SPAC charter until the merger agreement and voting materials are filed.

This filing establishes the baseline trust value ($57.5 million, or $10.00 per public share) and the 15-month deadline from August 7, 2025 (to November 2026) for completing a business combination. Investors should note that the sponsor has waived redemption rights and agreed to certain restrictions, and the company has a going concern risk if no deal is completed within the deadline. The working capital available outside the trust ($816,060) is modest, and the company will incur $10,000/month in administrative fees. No target has been announced, and the sponsor's conduct (repayment of promissory note, transfer of founder shares to officers/directors) is standard for a SPAC in the early post-IPO stage.

This filing locks the exact trust balance ($57,500,000) and public share count (5,750,000 ordinary shares subject to possible redemption) needed to track future redemption valuations. It defines a strict 15-month deadline from August 7, 2025, establishing the outer limit for any extension proposals or business combination announcements. The underwriting structure is clarified: A.G.P. received 2% cash underwriting discounts totaling $1,150,000 plus 3.5% equity compensation equaling 201,250 Representative Shares, which carry a 180-day FINRA Rule 51101(1) lock-up. The target acquisition criteria specify that combined targets must hold an aggregate fair market value of at least 80% of trust assets at agreement, and the post-transaction entity must secure 50% or more of outstanding voting securities to avoid Investment Company Act registration. The explicit going concern label and liquidity breakdown signal that capital preservation, timeline adherence, and sponsor-backed structural protections are the dominant near-term variables governing shareholder outcomes.

This 8-K establishes the SPAC's baseline financial structure: a trust with $57,500,000 ($10.00 per unit), a 15-month deadline to complete a business combination, insider lock-up and voting restrictions, and standard SPAC governance terms. Investors tracking redemption mechanics should note the articles require a minimum $5,000,001 in net tangible assets post-redemption and impose a 15% cap on any single beneficial owner's aggregate redemption rights. The document contains all standard IPO agreements but no target business or substantive revenue/operations claims, as the SPAC has just gone public.

This filing establishes all the baseline mechanics for tracking this newly listed SPAC. For investors, the key facts are: trust value of $10.00 per share, a 15-month deadline from the August 2025 effective date, a typical redemption structure, and a management team with significant ties to the PRC, which limits the potential pool of target companies and introduces China-specific risks.

Moving the registration effective date to August 7, 2025 advances the launch of the capital raise, which initiates the operating window during which the sponsor must identify and execute a target transaction. Earlier effectiveness compresses the pre-deadline runway, allowing net proceeds to fund due diligence, legalstructuring, and operational scaling immediately upon listing. Because the filing addresses only SEC procedural timing rather than asset valuation, revenue projections, or management track record, investors awaiting redemption pricing or merger-specific dilution metrics should treat this as a mechanical scheduling update and monitor subsequent amendments for underwriting economics and proposed acquisition disclosures.

Maples and Calder (Hong Kong) LLP advised that Cayman Islands public searches (e.g., court register, director register) do not disclose pending legal, arbitral, or administrative proceedings, nor internal steps toward liquidation, restructuring, or receiver appointment until formal filings are accepted by the Cayman court. Accordingly, the reinstated language in paragraph 8 of the revised opinion functions strictly as a factual representation from Company directors confirming the absence of such matters, explicitly clarifying that it does not assume or imply insolvency. Executive oversight is confirmed by the correspondence’s cc: line to Yan Liang, Chief Executive Officer, and Kong Wai Yap, Chief Financial Officer. The document contains no claims regarding customer concentration, revenue trajectories, total addressable market sizing, proprietary technology, strategic partnerships, ongoing litigation, or additional personnel appointments beyond the registered executive team.

Contractually removing the concurrent-release trigger confirms that SPAC cash remains fully locked in trust until merger closing, preserving shareholder redemption economics against premature trustee disbursement and satisfying Nasdaq Listing Rule IM-5101-2(a) deposit standards. The amendment eliminates a structural ambiguity in the trust account mechanics before any deal announcement, signaling compliance-driven document refinement rather than strategic pivoting. The filing contains no statements regarding target prospects, customer relationships, revenue projections, market sizing, technology pipelines, partnership terms, pending litigation, or executive compensation; the sole operative substance is the trust disbursement schedule adjustment and associated legal opinion cleanup.

The trust agreement is the core SPAC governance document — it establishes the $50M trust, the 15-month deadline to complete a business combination (subject to shareholder-approved extension), and the mechanics for per-share redemptions and trust liquidation. The legal opinion confirms the due authorization and non-assessable nature of shares, including the 1,437,500 founder shares issued to initial shareholders for $25,000 (~$0.017/share) and the sponsor’s commitment to purchase 232,121 private units at $10.00 each. The auditor consent allows the prospectus to rely on the company’s December 31, 2024 financial statements. Together, these exhibits complete the registration statement’s exhibit list and advance the SPAC’s path to effectiveness and its IPO.

These comments do not alter the SPAC’s original business combination window or default $10 trust value, but they impose a mandatory compliance checkpoint that could delay closing if the trust release mechanism is deemed non-conforming. Because Nasdaq requires the 90% threshold to be maintained through consummation, the company must revise the termination letter language or obtain a definitive staff ruling before transferring trust funds. Until the SEC Division accepts corrected amendments, deal progress remains stalled, and shareholders should expect no acceleration of fund distributions beyond the standard redemption calendar. All dates, phone numbers, file identifiers, rule citations, and conditional language are attributed directly to the SEC letter, the referenced company exhibits, and Nasdaq regulations.

For investors tracking redemption deadlines and trust mechanics, the explicit fifteen-month liquidation cutoff and conditional shareholder extension mechanism establish the hard timeline for cash returns or further delay. The restriction of trust assets to short-term Treasuries and qualifying money market funds caps downside risk, directly protecting the principal component of the '$50,000,000' (or '$57,500,000') pool. The provision isolating tax withdrawals to interest earnings ensures that redeeming shareholders’ pro rata principal cannot be eroded by franchise or income liabilities. The sponsor’s upfront '$25,000' founder share purchase and parallel private placement commitments at '$10.00' per unit financially tie management to successful acquisition execution, mitigating pre-combination dilution concerns. Because this is an exhibit-only amendment confirming operational and legal frameworks rather than revising pricing or target criteria, it solidifies the distribution mechanics but does not introduce new commercial terms; existing economic assumptions remain governed by the initial prospectus.

This filing updates the SEC registration statement with the first amendment, providing more complete disclosure. It is the primary registration document for this blank-check company’s IPO. The trust value is $10.00 per unit. The deadline to complete a business combination is 15 months from the effective date. The filing also details sponsor economics: 1,437,500 founder shares purchased for $25,000 ($0.017 per share), creating a significant incentive for the sponsor to complete any deal. The company acknowledges its ties to China and the associated regulatory risks. The S-1/A also includes the Underwriting Agreement, Lock-up Letter Agreement, Registration Rights Agreement, and Rights Agreement.

The document establishes the offering of 5,000,000 units at $10.00 per unit ($50,000,000 in trust), with a 15-month deadline from the effective date to complete a business combination. Sponsor paid $25,000 for 1,437,500 founder shares (~$0.017 per share), creating substantial dilution for public investors. Public shareholders have redemption rights (subject to a 15% cap per holder if seeking shareholder approval). The trust is $10.00 per share. Most management and the sponsor are based in China, making a China-based target more likely, exposing the SPAC to PRC regulatory risks (CSRC approvals, cybersecurity, PCAOB access). The filing also discloses a working capital deficit of $346,618 as of March 31, 2025, with a going concern opinion.

For investors tracking redemption deadlines, trust preservation, extensions, deal progress, and sponsor conduct, these amendments directly calibrate the regulatory and behavioral framework preceding an IPO and eventual de-SPAC transaction. The sponsor conduct revision on page 52 explicitly permits the sponsor to exit the search early by unconditionally transferring founder equity, introducing potential governance instability that could trigger extension requests or alter sponsor-retention strategies during the redemption period. The Rule 14e-5 compliance language on pages 55, 65, 117, and 143 governs how secondary buyers can accumulate shares ahead of a merger announcement, directly impacting liquidity dynamics, tender offer viability, and the speed at which the SPAC must complete a business combination to avoid prolonged listing suspension. The China-linked operational risk disclosure on the cover page signals jurisdictional and geopolitical friction that may delay target identification, complicate cross-border due diligence, and influence whether shareholders exercise redemption rights or vote to extend financing timelines. The ASC 280 accounting realignment on page F-14 standardizes financial transparency, ensuring that underwriters, auditors, and special purpose acquisition vehicle sponsors track operating costs and net performance accurately during valuation negotiations. The Company, through its disclosed submissions, does not confirm a specific trust account balance, set a redemption calendar, name a target, or finalize partnership agreements; instead, it establishes the pre-effective disclosure baseline that dictates how sponsor leverage, shareholder liquidity, and regulatory compliance will interact once public trading commences.

Substantive reporting beyond structural mechanics includes governance concentration, sponsor exit flexibility, and accounting methodology under ASC 280-10-50-28A through 50-28C and 280-10-50-26A and 50-26B, all asserted by the Division of Corporation Finance. As stated by SEC staff, these items indicate unresolved regulatory review that precedes any effectiveness trigger for the registration statement, meaning no business combination target has been identified, no redemption deadline has been set, and the SPAC remains in its SEARCHING phase. For investors tracking deal progress and sponsor conduct, the emphasis on Rule 14e-5 voting boundaries, founder share transfer mechanics, and geographic leadership concentration signals potential structural negotiations that could delay extension filings, alter tender offer parameters, or reshape redemption behavior once a deal emerges. Financial transparency directives (page 56, page F-9) further condition pre-deal disclosure quality. Correspondence routes financial queries to Ameen Hamady at 202-551-3891 or Kristina Marrone at 202-551-3429, and general inquiries to Isabel Rivera at 202-551-3518 or Pam Howell at 202-551-3357, with copy sent to Jia Yan from 418 Broadway #7531 Albany, NY 12207. All assertions reflect Division of Corporation Finance commentary dated April 21, 2025.

Sets forth the complete economic and structural terms for a new SPAC with a China-connected sponsor, including trust per-share value, redemption mechanics, extension provisions, potential dilution at various redemption levels, and extensive risk disclosures related to China operations and regulation.

For investors tracking redemption calendars and trust preservation, the explicit instruction that dissolution expenses be funded from non-trust assets during extensions or mergers safeguards the aggregate deposit remaining in the trust, ensuring the per-share redemption price is not eroded by administrative fee draws. Disclosing extension limits and sponsor consequences defines the exact timeline window shareholders must evaluate before redemption rights potentially lapse. The 20.0% ownership maintenance clause highlights a documented structural dilution pathway tied to offering size adjustments, which directly affects pro forma net tangible book value metrics. Finally, attributing leadership ties to China and mapping CAC regulatory oversight alerts shareholders to jurisdictional friction points that could delay target selection or complicate post-merger listing eligibility, while the sponsor sale restrictions and fiduciary conflict disclosures establish governance boundaries relevant to any upcoming merger vote.

Because the Form S-1 remains in draft form, the SEC staff has not cleared the effective date, meaning the IPO cannot close, the trust account cannot be fully funded, and the statutory countdown to complete an initial business combination does not commence. Any revision to the trust distribution language—especially regarding the $100,000 dissolution expense carve-out versus Nasdaq Rule IM-5101-2(d) pro rata redemption rights—will directly dictate the exact per-share cash public shareholders receive upon exercising redemption rights at merger or extension votes. Clarifying extension caps and sponsor default consequences establishes the maximum temporal runway before forced liquidation and dictates whether management must secure additional working capital or face forfeiture of founder equity. The mandated tabulation of sponsor lock-ups, affiliate sales restrictions, and direct/indirect interests reveals insider supply constraints and aligns incentives ahead of any target announcement. Heightened regulatory scrutiny over China-based leadership, Cyberspace Administration of China data protocols, and anti-monopoly enforcement creates actionable risk parameters that may narrow the investable universe, increase compliance overhead, or depress valuation multiples for cross-border targets. Expanding dilution disclosures beyond the table and formalizing the mechanics behind maintaining a 20.0% founder stake against the $8.75 per-share baseline will allow investors to model post-offering NAV erosion accurately before capital deploys. Until the comment letter is resolved and a revised prospectus files, redemption pricing parameters, extension flexibility, and sponsor capital constraints remain administratively undefined.

The filing provides the first detailed look at this SPAC's structure, including a $10.00 per-share trust, a 12-month completion window, significant China-related risks (sponsor and most management are PRC-based), and the sponsor's low-cost founder shares ($0.017 per share). It also reveals that the SPAC has no target identified and no substantive discussions with any potential business combination candidate. Investors should note the substantial dilution to public shareholders and the potential for regulatory hurdles if a PRC target is pursued.

This filing advances the company toward execution by formally triggering SEC confidential review, establishing a clear 15-day pre-road show public disclosure threshold that investors can track for marketing initiation. The one-seventh (1/7) right structure defines post-combination equity dilution, which directly impacts future redemption valuation floors and right exercise economics. Although the search phase persists without target identification or trust disclosures, the confirmed corporate governance, emerging growth company status, and active legal counsel engagement signal operational readiness ahead of the prospectus circulation window.

What changed: Starry Sea Acquisition Corp.'s first annual report on Form 10-K for fiscal year ended December 31, 2025, filed April 2, 2026 — a blank-check/SPAC annual filing covering the IPO, trust account, business combination search, and the status of the proposed Forever Young transaction. No definitive business combination agreement has been signed. The September 29, 2025 letter of intent with Forever Young International Limited remains in an exclusivity period, with pre-money equity value of approximately $750 million to $900 million and consideration expected as rollover equity in the post-closing entity at $10 per share. The trust account held $58,363,263 at December 31, 2025, and the 5,750,000 public shares subject to possible redemption were carried at $10.12 per share. Cash outside the trust was $112,134 and working capital was $379,066. The 15-month combination period is measured from August 7, 2025 — the registration statement's effective date, also described in the filing as 15 months from closing — and no extension has been approved. The over-allotment was exercised in full, 201,250 representative shares were issued, and no founder shares were forfeited. Why it matters: For investors tracking redemption and liquidation mechanics, this filing establishes the year-end trust value and per-share redemption amount, confirms the company remains in search mode with only a non-binding LOI, and highlights limited cash outside trust ($112,134) against ongoing public-company costs and the risks of running to the deadline. If completed, the proposed Forever Young deal would be valued at roughly $750 million to $900 million pre-money, but the lack of a definitive agreement, potential public-share redemptions, and possible extension or liquidation remain the key open items.

What changed: SEC Form 12b-25 Notification of Late Filing for the Annual Report on Form 10-K. This filing formally notifies the Securities and Exchange Commission that Starry Sea Acquisition Corp will miss its statutory deadline for the Form 10-K covering the fiscal year ended December 31, 2025. Through CEO Yan Liang, executed and dated March 31, 2026, the company states it needs additional time to complete the audited financial statements and asserts that filing on schedule would require 'unreasonable effort or expense.' The registrant commits to submitting the annual report within fifteen calendar days of the original deadline. It answers affirmatively that all prior Section 13 or 15(d) periodic reports were filed on time and negatively that any significant change in results of operations is anticipated. The document contains no operational disclosures, financial metrics, target identifiers, market sizing, technology assessments, partnership terms, litigation references, or personnel movements beyond the executive signature and contact details. Why it matters: For a SPAC still searching for a business combination, a Form 12b-25 automatically triggers charter-based extension mechanisms that freeze the redemption calendar and suspend shareholder voting rights until the 10-K is filed. The delay signals unresolved accounting, internal controls, or audit coordination ahead of a potential acquisition, extending the period during which the trust account remains idle and sponsorship expenses draw down working capital. Because the notification provides zero update on deal search progress, valuation targets, or timeline adjustments, investors must treat capital deployment expectations as unchanged while monitoring whether subsequent filings restore trading eligibility. Sponsors who fail to meet extended deadlines risk forced liquidation at the then-current per-share trust balance, making strict tracking of the fifteen-calendar-day cure window critical. All characterizations of the delay rationale, cure timeline, and absence of operational changes derive exclusively from the Company and CEO Yan Liang as filed.

What changed: Routine compliance exhibit — Schedule 13G/A amended beneficial ownership report. The filing text identifies only the document type, filing identifier, and holder (Highbridge Capital Management, LLC). It contains no disclosed share counts, ownership percentages, or amendments affecting redemption deadlines, trust value per share, extension mechanics, business combination progress, or sponsor conduct. The reporting entity makes no substantive assertions beyond acknowledging its own filing status. Why it matters: Because the excerpt lacks attached schedule data detailing changed share quantities, voting arrangements, or disposal rights, it does not alter the calculus around cash-redemption windows, unit conversion timing, or target-acquisition pipelines. In the absence of attributed claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel, investors tracking SPAC operational milestones should treat this as a standard regulatory update with no immediate impact on deal economics or sponsor behavior.

What changed: Routine compliance exhibit: a Schedule 13G/A beneficial ownership report filed by Space Summit Capital LLC for STARRY SEA ACQUISITION CORP. The excerpt identifies Space Summit Capital LLC as the reporting holder but discloses no share quantities, acquisition dates, purchase prices, ownership percentages, voting arrangements, or purpose statements. Regarding mechanics—redemption deadlines, trust value, extensions, deal progress, and sponsor conduct—the text provides zero operative data: there are no indications of accumulated positions, redemption intentions, extension voting triggers, business combination milestones, or sponsor commitments. Why it matters: No claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel are present, and none are attributed to Space Summit Capital LLC or the registrant in this excerpt. Materiality for SPAC tracking requires explicit numerical disclosures and stated purposes that could signal control changes, proxy influence, or merger timing shifts; because the text contains no such figures or assertions, it currently carries no actionable weight. Full assessment depends on the complete filing’s body, which would show actual share totals, transaction dates, and investment purpose.

What changed: Amended Schedule 13G beneficial ownership report and Exhibit A Joint Filing Agreement. This document IS an amended Schedule 13G accompanied by a joint filing agreement executed under Rule 13d-1(k). Bearing on the requested mechanics: The filing reports zero changes to SSEA’s redemption deadlines, trust account valuation mechanics, extension voting procedures, business combination timeline, or sponsor conduct. It does not indicate deal progress, negotiations, or alterations to public shareholder rights. Bearing on other substance: The document contains no claims regarding customers, revenue, market size, corporate strategy, technology, partnerships, litigation, or personnel. No operating companies, target assets, or financial projections are referenced. It solely formalizes that the Harraden Circle family of funds and affiliates, managed under the oversight of Frederick V. Fortmiller, Jr., will continue reporting their aggregate SSEA position through a single amended schedule. The execution date is February 13, 2026, and the SEC accession number is 0001193125-26-051874. Why it matters: For investors tracking redemption windows, trust distribution rules, or acquisition milestones, this filing carries no material impact. It confirms administrative continuity and centralized signing authority via Mr. Fortmiller for the Harraden Circle vehicles, but introduces no new financing conditions, target criteria, or governance changes that would affect shareholder economics or decision timelines. Routine compliance filings of this nature do not shift valuation assumptions or trigger protective triggers, though they verify the unified reporting structure controlling the disclosed stake.

What changed: Routine compliance exhibit attached to a Schedule 13G. In its own terms, it contains Exhibit A and Exhibit B: Limited Powers of Attorney executed by Mizuho Financial Group, Inc., Mizuho Bank, Ltd., Mizuho Americas LLC, and Mizuho Securities USA LLC to authorize designated officers to execute and file Form 13G with the SEC. As stated by the authorized representatives (Takahiro Katsura, Hidekatsu Take, and Adam Hopkins), the documents delegate full authority to complete, amend, supplement, and timely file Form 13G and related exhibits. This reflects a standard administrative update for institutional ownership reporting. It reports no modifications to redemption deadlines, trust value calculations, extension procedures, merger deal progress, or sponsor conduct. The filing references a date of 2-12-2026 and lists principal office locations at 1-5-5, Otemachi, Chiyoda-ku, Tokyo 100-8176, Japan; and 1271 Avenue of the Americas, NY, NY 10020, USA. Why it matters: For investors tracking capital event mechanics, this filing bears zero relevance. It is a procedural instrument confirming signatory authorization for regulatory submissions, not a disclosure of economic or operational shifts. As articulated by the executing Mizuho officers, the text contains no substantive claims about customer concentration, revenue streams, addressable market size, strategic initiatives, proprietary technology, partnership formations, active litigation, or executive turnover. All statements are confined to the granting of form-filing agency, making it immaterial to redemption thresholds, trust integrity, extension timelines, acquisition targets, or sponsor fidelity.

What changed: Routine compliance exhibit — Amended Schedule 13G beneficial ownership report. The filing updates prior disclosures for Wolverine Asset Management, LLC, Wolverine Holdings, LLC, Christopher L. Gust, and Robert R. Bellick. The provided excerpt omits the amended share quantity, percentage of outstanding common stock, triggering event date, and statement of investment purpose. Why it matters: Regarding redemption mechanics, trust value, extensions, deal progress, and sponsor conduct: this 13G/A is filed while SSEA remains in the SEARCHING phase with no announced target, merger agreement, or extension resolution. It does not establish a voting block capable of forcing a business combination deadline acceleration, nor does it indicate sponsor willingness to waive anti-dilution provisions or preserve the per-share trust amount noted at $10. Because the numerical holdings and investment intent are absent from the excerpt, the amendment carries no actionable impact on the redemption calendar or trust accounting. As a standard regulatory update, it simply logs institutional tracking of SSEA’s equity without signaling strategic maneuvering, customer metrics, revenue projections, technology development, partnership announcements, litigation exposure, or executive personnel shifts. The reporting persons have not publicly claimed customer concentrations, revenue trajectories, market sizing, technology roadmaps, partner agreements, active litigation, or leadership changes in this submission.

What changed: a Joint Filing Agreement (a routine compliance exhibit attached to a Schedule 13G/A). According to the undersigned signatories—Feis Equities LLC and Lawrence M. Feis—the document formally consolidates their SEC reporting obligations, agreeing that the Schedule 13G regarding Class A ordinary shares of Starry Sea Acquisition Corp dated January 30,2026 and any subsequent amendments shall be filed jointly on behalf of each party pursuant to Rule 13d-1(k). This exhibit discloses no modifications to SSEA’s redemption deadline, trust account balance, extension vote mechanics, target acquisition timeline, or sponsor leadership conduct. Why it matters: Investors monitoring SSEA’s liquidation windows, trust preservation, or de-SPAC execution will find this exhibit procedurally neutral. It solely coordinates regulatory submission logistics for beneficial ownership tracking and contains no assertions regarding customer contracts, revenue streams, market positioning, technological capabilities, partnership arrangements, pending litigation, or executive compensation. The filing advances no operational milestones and requires no shareholder action beyond routine disclosure compliance.

What changed: This document is a Schedule 13G beneficial ownership report. The filing identifies HIGHBRIDGE CAPITAL MANAGEMENT, LLC as the reporting holder. The provided text contains no share quantities, acquisition dates, purchase prices, or transaction structures, and therefore reports no changes to redemptions, trust value mechanics, extension timelines, target acquisition progress, or sponsor conduct. Why it matters: Under SEC rules, filing a Schedule 13G means the holder asserts it holds more than 5 percent of the registrant’s securities, signaling institutional tracking of STARRY SEA ACQUISITION CORP during its SEARCHING phase. Because the excerpt does not disclose the exact number of shares, aggregate cost, or whether the interest is passive or controlled, the filing alone does not alter redemption parameters, affect trust distribution calculations, or provide evidence of deal advancement or sponsor activity.

What changed: Schedule 13G — a routine compliance exhibit disclosing beneficial ownership. The filing identifies WOLVERINE ASSET MANAGEMENT LLC, Wolverine Trading Partners, Inc., Wolverine Holdings, L.P., Gust Christopher, and Robert R. Bellick as reporting holders. The document text contains no statements updating redemption deadlines, trust account funding levels, extension proposals, target acquisition negotiations, or sponsor fiduciary conduct. Why it matters: This filing serves as a cumulative ownership disclosure triggered by cross-entity accumulation above the statutory reporting threshold. For SSEA investors monitoring cash conversion timelines, tender mechanics, or management alignment with shareholder interests, the document provides zero operational or procedural leverage; it neither narrows the acquisition window nor alters trust distribution parameters. The excerpt makes no assertions regarding customer pipelines, revenue recognition, market sizing, technological moats, commercial partnerships, active litigation, or executive succession. All referenced holding vehicles are attributed exclusively to the Wolverine reporting group as stated in the filing’s disclosure header.